BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. In connection with the offering, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback